- Supported exchanges /
- F /
- 52Q.F
AEGIRBIO AB (52Q F) stock market data APIs
Magnasense AB, a diagnostic company, develops and commercializes tests for monitoring and optimizing the dosage of biological drugs Sweden and internationally. The company focuses on the neurology, oncology, and autoimmune therapeutic areas. It offers moNATor, a first dose-monitoring laboratory test that provides multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. The company was formerly known as AegirBio AB (publ) and changed its name to Magnasense AB in July 2024. Magnasense AB was incorporated in 2019 and is headquartered in Lund, Sweden.
AEGIRBIO AB Financial Data Overview
| 0.0152 | |
| 0.0144 | |
| - | |
| 0.0156 | |
| 0.0144 | |
| 0.0142-0.1111 | |
| 881 K | |
| 49 249 K | |
| 35 000 | |
| 2.635 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
AEGIRBIO AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 35 000
- EBITDA -24 520 500
- Earnings Per Share -0.15
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get AEGIRBIO AB Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get AEGIRBIO AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
